Abstract
Background A 48-year-old woman who was diagnosed with type 1 diabetes at 5 years of age presented to our Clinical Islet Transplant Program with severe, recurrent hypoglycemia and glycemic lability. She was diligent with her diet, used a continuous subcutaneous insulin infusion pump (32 U per day), and monitored her glucose levels typically eight times a day. The patient usually had one hypoglycemic reaction a day, experienced a severe reaction once a month, and had marked variability of her glucose values. On presentation, her HYPO score was 584 and her lability index was 868 mmol/l2/h per week.
Investigations HYPO score, lability index score, screening for diabetes complications, and routine pretransplant evaluation.
Diagnosis Severe, recurrent hypoglycemia and glycemic lability associated with type 1 diabetes.
Management The patient underwent islet transplantation. Post-transplant, the problems with hypoglycemia abated and excellent stable glycemic control was attained, although some side effects from the immunosuppressive drug, sirolimus, were evident. Insulin was reinstituted 2.5 years after surgery, at lower doses than before the transplant because of deterioration in graft function. Occasional episodes of hypoglycemia have occurred and some glycemic lability has recurred, although endogenous insulin secretion is still preserved.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ryan EA et al. (2004) Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 53: 955–962
Pedersen-Bjergaard U et al. (2004) Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev 20: 479–486
Cryer PE et al. (2003) Hypoglycemia in diabetes. Diabetes Care 26: 1902–1912
Gosmanov NR et al. (2005) Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans. Diabetes Care 28: 1124–1131
Cryer PE (2004) Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350: 2272–2279
Cryer PE (1992) Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious cycle. Diabetes 41: 255–260
Fanelli C et al. (1994) Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia 37: 1265–1276
Bode B et al. (2004) Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system. Diab Technol Therap 6: 105–113
Clarke WL et al. (1995) Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care 18: 517–522
Ryan EA et al. (2005) Five-year follow-up after clinical islet transplantation. Diabetes 54: 2060–2069
Senior PA et al. (2005) Proteinuria developing after clinical islet transplantation resolves with sirolimus withdrawal and increased tacrolimus dosing. Am J Transplant 5: 2318–2323
Cure P et al. (2004) Alterations of the female reproductive system in recipients of islet grafts. Transplantation 78: 1576–1581
Hering BJ et al. (2005) Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 293: 830–835
Froud T et al. (2005) Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 5: 2037–2046
Rickels MR et al. (2005) Islet cell hormonal responses to hypoglycemia after human islet cell transplantation for type 1 diabetes. Diabetes 54: 3205–3211
Paty BW et al. (2002) Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes 51: 3428–3434
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ryan, E., Shapiro, A. A patient with severe, recurrent hypoglycemia and glycemic lability who underwent islet transplantation. Nat Rev Endocrinol 2, 349–353 (2006). https://doi.org/10.1038/ncpendmet0201
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpendmet0201
This article is cited by
-
Islet cell transplantation today
Langenbeck's Archives of Surgery (2007)
